Publication

Racial and Ethnic Disparities in Kidney Replacement Therapies Among Adults with Kidney Failure: An Observational Study of Variation by Patient Age

Downloadable Content

Persistent URL
Last modified
  • 06/25/2025
Type of Material
Authors
    Adam Wilk, Emory UniversityJanet Cummings, Emory UniversityLaura Plantinga, Emory UniversityHarold Franch, Emory UniversityJanice Lea, Emory UniversityRachel Patzer, Emory University
Language
  • English
Date
  • 2022-07-01
Publisher
  • W B SAUNDERS CO-ELSEVIER INC
Publication Version
Copyright Statement
  • © 2022 by the National Kidney Foundation, Inc.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 80
Issue
  • 1
Start Page
  • 9
End Page
  • 19
Grant/Funding Information
  • The authors’ work was supported in part by the National Institute of Diabetes and Digestive and Kidney Diseases (K01-DK128384) and the National Institute on Minority Health and Health Disparities (U01-MD010611). Neither Institute had any role in study design, data collection, analysis, reporting, or the decision to submit for publication.
Supplemental Material (URL)
Abstract
  • Rationale & Objective: Non-Hispanic Black and Hispanic patients present with kidney failure at younger ages than White patients. Younger patients are also more likely to receive transplants and home dialysis than in-center hemodialysis (ICHD), but it is unknown whether racial and ethnic disparities in treatment differ by age. We compared use of kidney replacement therapies between racial and ethnic groups among patients with incident kidney failure overall and by age. Study Design: Retrospective cohort study. Setting & Participants: 830,402 US adult (age >21 years) patients initiating kidney failure treatment during the period of 2011-2018. Exposures: Patient race and ethnicity (non-Hispanic Black, non-Hispanic White, Hispanic, or other) and age group (22-44, 45-64, 65-74, or 75-99 years). Outcome: Treatment modality (transplant, peritoneal dialysis [PD], home hemodialysis [HHD], or ICHD) as of day 90 of treatment. Analytical Approach: Differences in treatment modalities were quantified for patient subgroups defined by race and ethnicity and by age. Log-binomial regression models were fit to estimate adjusted risk ratios. Results: 81% of patients were treated with ICHD, 3.0% underwent transplants (85% preemptive, 57% living-donor), 10.5% were treated with PD, and 0.7% were treated with HHD. Absolute disparities in treatment were most pronounced among patients aged 22-44 years. Compared with non-Hispanic White patients, whose percentages of treatment with transplant, PD, and HHD were 10.9%, 19.0%, and 1.2%, respectively, non-Hispanic Black patients were less commonly treated with each modality (unadjusted percentages, 1.8%, 13.8%, and 0.6%, respectively), as were Hispanic patients (4.4%, 16.9%, and 0.5%, respectively; all differences P < 0.001). After adjustment, the largest relative disparities were observed for transplant among the 22-44–year age group; compared with non-Hispanic White patients, the adjusted risk ratios for non-Hispanic Black and Hispanic patients were 0.21 (95% CI, 0.19-0.23) and 0.47 (95% CI, 0.43, 0.51), respectively. Limitations: Race and ethnicity data not self-reported. Conclusions: Among adults with incident kidney failure, racial and ethnic disparities in transplant and home dialysis use are most pronounced among the youngest adult patient age group.
Author Notes
Keywords
Research Categories
  • Health Sciences, Medicine and Surgery
  • Health Sciences, Health Care Management

Tools

Relations

In Collection:

Items